September 6, 2024
TOPLINE: The presence of an operational classification of drug interactions (ORCA) class 3 or 4 drug-drug interactions (DDIs) did not increase the risk for colchicine-related gastrointestinal […]
September 6, 2024
TOPLINE: Middle-aged adults who consume more ultra-processed foods have an elevated risk for rheumatoid arthritis (RA) that is mediated in part through circulating biomarkers. METHODOLOGY: Investigators […]
September 6, 2024
TOPLINE: In systemic sclerosis, Raynaud phenomenon is more severe at both high and low temperature extremes, according to new research. BACKGROUND: Raynaud phenomenon, a condition that […]
September 5, 2024
Hematologists and rheumatologists may be able to adopt a more aggressive approach for managing low-grade marginal lymphoma in Sjögren disease, particularly mucosa-associated lymphoid tissue (MALT) lymphoma, […]
September 4, 2024
TOPLINE: Teclistamab, a T-cell engager that targets B-cell maturation antigen (BCMA), improved disease activity in four patients with refractory autoimmune conditions. In a separately published case […]
September 4, 2024
TOPLINE: Patients with both rheumatoid arthritis (RA) and atrial fibrillation (AF) have a higher risk for ischemic stroke than those with only AF. They are also […]
September 4, 2024
TOPLINE: Higher rheumatoid arthritis (RA) disease activity is associated with an accelerated kidney function decline and increased risk for chronic kidney disease (CKD) stages G3a and […]
September 2, 2024
TOPLINE: Systemic sclerosis sine scleroderma (ssSSc) affects nearly 10% of patients with systemic sclerosis (SSc), with substantial internal organ involvement. Despite lacking skin fibrosis, patients with […]
August 30, 2024
A US government report showed how a Medicare policy change made the drug ustekinumab (Stelara) for autoimmune diseases much more expensive, a finding that experts say […]